Conmed Corp (NYSE:CNMD) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET
Company Participants
Curt Hartman - Chairman, CEO & President
Todd Garner - EVP & CFO
Conference Call Participants
Lilia-Celine Breton Lozada - JPMorgan Chase & Co.
Rick Wise - Stifel, Nicolaus & Company
Michael Matson - Needham & Company
Matthew Mishan - KeyBanc Capital Markets
Operator
Good day, and thank you for standing by. Welcome to the First Quarter Fiscal Year '22 CONMED Earnings Conference Call. [Operator Instructions].
With us today are Curt Hartman, President and CEO; and Todd Garner, Executive Vice President and Chief Financial Officer.
I would like to now turn the conference over to CONMED. Please note this conference is being recorded.
Unidentified Company Representative
Good afternoon, everyone. Before the conference call begins, let me remind you that during this call, management will be making comments and statements regarding its financial outlook and its plans and objectives, which represent forward-looking statements that involve risks and uncertainties as those terms are defined under the federal securities laws. Investors are cautioned that any such forward-looking statements are not guarantees of future events, performance or results, and the company's actual results may differ materially from its current expectations.
Please refer to the risks and other uncertainties disclosed under forward-looking information in today's press release as well as the company's SEC filings for more details on the risks and uncertainties that may cause actual results to differ materially. The company disclaims any obligation to update any forward-looking statements that may be discussed during this call, except as may be required by applicable law.
You will also hear management refer to certain non-GAAP adjusted measurements during this discussion. While these figures are not a substitute for GAAP measurements, management uses these figures to aid in monitoring the company's ongoing financial performance from quarter-to-quarter and year-to-year on a regular basis and for benchmarking against other medical technology companies. Adjusted net income and adjusted earnings per share measure the income of the company, excluding credits or charges that are considered by the company to be special or outside of its normal ongoing operations. These adjusting items are specified in the reconciliations supporting the company's earnings releases posted to the company's website.
With these required announcements completed, I will turn the call over to Curt Hartman, CONMED's Chair of the Board, President and Chief Executive Officer, for opening remarks. Mr. Hartman?